Topical Antiviral gel shows promise in managing molluscum contagiosum: Study Dr Satabdi Saha18 Jun 2021 8:45 AM ISTMolluscum is a common, contagious skin infection caused by the molluscipoxvirus, affecting approximately six million people in the U.S. annually,...
Management of "Maskne" & Other Mask Related Facial Dermatoses: BMJ Dr Kartikeya Kohli17 Jun 2021 9:30 AM ISTThe covid-19 pandemic has led to a marked increase in the use of personal protective equipment (PPE) both in and out of healthcare settings. Mask...
StrataGraft for treatment of thermal burns gets FDA approval Hina Zahid16 Jun 2021 10:45 AM ISTUSA: The U.S. Food and Drug Administration has given approval to StrataGraft for the treatment of adult patients with thermal burns. Thermal burns are...
Guselkumab improves quality of life in patients with moderate-to-severe psoriasis, Study says Dr. Nandita Mohan15 Jun 2021 9:30 AM ISTAccording to recent research, it has been found out that guselkumab maintains high levels of clinical response and patient-reported outcome (PRO) ...
Chronic inflammatory skin diseases not linked to VTE risk, finds JAMA study Dr Satabdi Saha14 Jun 2021 9:45 AM ISTIn a recent large-scale cohort study, chronic inflammatory skin diseases (CISDs) were not associated with an increased incidence of venous...
Vitamin D deficiency increases addictive behavior for opioid and UV rays: Study Hina Zahid14 Jun 2021 9:00 AM ISTUSA: Vitamin D deficiency increases the risk for opioid addiction and dependence by strongly exaggerating the craving for and effects of opioids,...
FDA Expands Use of RECELL System for Treating Extensive Burns and Pediatric Patients Hina Zahid12 Jun 2021 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved expanded use of the RECELL System in combination with meshed autografting for the treatment...
Vitamin D deficiency linked to increased SLE activity: Study Medha Baranwal9 Jun 2021 9:00 AM ISTKarachi, Pakistan: Vitamin D deficiency is common in systemic lupus erythematosus (SLE) patients and also significantly increases disease activity,...
Dupilumab may Raise Risk of Ocular Disease in Atopic Dermatitis Patients: Study Josepha James8 Jun 2021 9:15 AM ISTDupilumab is the first human monoclonal antibody approved for the treatment of atopic dermatitis (AD). However, a recent study suggests that the use...
Immunoglobulin in high dose boosts treatment response in dermatomyositis: ProDERM study Josepha James7 Jun 2021 9:00 AM ISTDermatomyositis (DM) is an inflammatory myopathy characterized by distinct skin manifestations and muscle weakness. Although the precise pathogenesis...
Oxybutynin cream applied twice daily effective treatment of axillary hyperhidrosis: Study Medha Baranwal6 Jun 2021 9:00 AM ISTAthens, Greece: A cream formulation of oxybutynin chloride (OC) 10% is safe and well-tolerated anticholinergic therapy for the treatment of primary...
Baricitinib- a long term treatment option for moderate to severe atopic dermatitis Dr. Nandita Mohan4 Jun 2021 8:15 AM ISTAccording to recent research, investigators from the Department of Dermatology, George Washington University School of Medicine, Washington, DC have...
